Insulin-dependent (type 1) diabetes mellitus (100M) is a multifactorial disease with a strong genetic component. The pathological lesion is autoimmune destruction of the insulin-containing beta cells. The process is likely to be initiated by an environmental factor, perhaps as early as in intra-uterine life. This then leads to progressive beta cell destruction which can go on for 5-15 years before the first symptoms. The clinical presentation with symptoms of hyperglycaemia and/or diabetic ketoacidosis typically occurs in weeks; at this stage, approximately 80% of beta cells are destroyed. What is not known is whether the beta cell can recover from the early stages of destruction. As will be discussed later, there is evidence to indicate that some patients with non-insulin-dependent (type 2) diabetes mellitus (NIOOM) may have gone through an aborted 'type l' process. What is clear, however, is that the majority with the genetic predisposition do not sub sequently develop 100M (see the monozygotic twin evi dence below). In contrast to the rapid progress in identifying the genetic component of 100M, the search for environmental factors has been enigmatic, with viruses, diet and toxins being implicated.
The majority of the genetic component can be explained by associations between IDDM and genes in the major histocompatibility complex (MHC). The best single marker for IDDM is based on amino acid polymorphism of the HLA-DQ gene. Current evidence, however, indi cates that the MHC susceptibility to IDDM is determined by a combination of HLA class I, II and III genes con tained on HLA haplotypes. A non-MHC genetic com ponent to IDDM also exists. To date, the most consistent association is between IDDM and markers of the insulin gene locus.
ENVIRONMENTAL FACTORS
Insulin-dependent (type 1) diabetes mellitus (100M) is a multifactorial disease with a strong genetic component. The pathological lesion is autoimmune destruction of the insulin-containing beta cells. The process is likely to be initiated by an environmental factor, perhaps as early as in intra-uterine life. This then leads to progressive beta cell destruction which can go on for 5-15 years before the first symptoms. The clinical presentation with symptoms of hyperglycaemia and/or diabetic ketoacidosis typically occurs in weeks; at this stage, approximately 80% of beta cells are destroyed. What is not known is whether the beta cell can recover from the early stages of destruction. As will be discussed later, there is evidence to indicate that some patients with non-insulin-dependent (type 2) diabetes mellitus (NIOOM) may have gone through an aborted 'type l' process. What is clear, however, is that the majority with the genetic predisposition do not sub sequently develop 100M (see the monozygotic twin evi dence below). In contrast to the rapid progress in identifying the genetic component of 100M, the search for environmental factors has been enigmatic, with viruses, diet and toxins being implicated. 1 Evidence for
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Eye (1993) 7,209-213 viruses being pathogenic for 100M is indirect except in rare instances of overwhelming viral infection. An interesting example is congenital rubella, which is associ ated with increased risk of mainly 100M although NIOOM has also been reported. This in utero infection leads to 100M with a similar age of onset and immuno genetic predisposition to idiopathic 100M.2 Examples of toxins include nitrosamines, pyriminil and pentamidine; however, these are again rare causes. Amongst the most frequently implicated dietary factors are dietary proteins, the current favourite being cow's milk. 3 
THE GENETIC COMPONENT TO IDDM
Indirect evidence implicating genetic factors in 100M comes from the study of monozygotic twins and family studies. 100M clusters in families, although only 5% of diabetics have a family history of 100M. Familial clus tering is not proof of a shared genetic determinant as it may equally be due to common environment. In twin stud ies one identifies a monozygotic (identical) twin who has 100M and then determines how frequently the co-twin also has the disease. The largest series comes from the studies of Leslie and Pyke who collected a series of 200 twin pairs in which the concordance for 100M was 30%.4 These studies are, however, limited as there are no large series of dizygotic (not necessarily identical) twins to act as environmental controls. Furthermore, some monozy gotic twins share the same placenta and would, therefore, be exposed to the same intra-uterine environmental factors.
The main evidence for the genetic component to 100M has come from the demonstration of an association of the disease with genes in the major histocompatibility com plex (MHC). In particular, in families with more than one child with 100M, the diabetic children share the same MHC genes more frequently than would be expected by chance.5 The MHC is not the complete answer, however, as only 15% of MHC-identical siblings develop 100M compared w i th 30% of genetically identical twins. This would, therefore, imply that genes outside the MHC also contribute to the genetics oflOOM.
THE MAJOR HISTOCOMPATIBILITY COMPLEX AND HLA ASSOCIATIONS
The MHC is located on the short arm of chromosome 6 in a region spanning 3500 kilobases (kb). There is little recombination within this region. This leads to the phenomenon of linkage disequilibrium, whereby combi nations of alleles at different loci preferentially associate with each other; an example would be HLA-AI, -BS, -DR3, which are found in a higher frequency together (a so-called haplotype) than would be predicted by their indi vidual gene frequencies. The MHC is subdivided into three main regions (Fig. 1) . The class I region contains genes for HLA-A, -B, -C, -E, -F and -G genes. HLA-A, -B and -C are expressed on the surface of all nucleated cells. They are composed of three a chains and 13 2 -microglobu lin (the latter coded for by a gene outside the MHC). Given a gene density of 1 in 25 kb in the class III and II regions it is likely that there are many more genes to be found in the class I region than have hereto been identified. The class III region is the most densely mapped region of the MHC. Some of the genes found in this region are those for tumour necrosis factors a and 13, heat shock protein 70 (HSP70), complement C4, complement C2, 21-hydro xylase, properdin Bf and the so-called BAT genes. The class II region contains the genes for HLA-DR, -DQ, -ON, -DO and -DP, certain collagen genes and transporter asso ciated peptides (TAP). Class II antigens are expressed on the surface of macrophages, B lymphocytes, activated T helper cells, monocytes, some epithelial cells and melan oma cells. There is a question whether in IDDM class II antigens are aberrantly expressed on the surface of islet beta cells.6 The HLA class II antigens are comprised of an a and 13 chain encoded by separate genes, i.e the HLA-DQ molecule is coded for by a DQAI and a DQBl gene.
What is the function of HLA molecules? Foreign anti gen is endocytosed by an antigen-presenting cell where upon it is enzymatically degraded and then transported to the cell surface in association with an HLA molecule. At the cell surface an HLA molecule presents the antigen to a T cell receptor, triggering a sequence of events leading to the clearance of antigen and antigen-presenting cell. IDDM is thought to be an autoimmune disease triggered by either a foreign antigen or a self-antigen presented by the beta cell. The beta cell thus becomes the target of immune destruction. HLA associations with IODM were first noted for the class I antigens HLA-AI-BS and HLA B15.7 With the discovery of the class II antigens, closer The human major histocompability complex (3500 kilobases).
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associations were found between IDDM and HLA-DR3, -OR4, -DR3/DR4 and -DR2 (OR2 being protective) ( Table 1 ).8-10 The best single markers for IDDM are in the HLA-DQ region and are identified by sequence variation of the gene coding for HLA -DQa (with arginine present in position 52) and HLA-DQI3 (with an amino acid other than aspartate at position 57).11.12 These IODM-predis posing markers are identified using the polymerase chain reaction and allele-specific oligomer probes. No single marker is found in IDDM subjects throughout the world, although in Caucasoid popUlations strong associations are found with HLA-DQAl *0301 and HLA-DQBl *0302. There are also interesting differences within Europe, where the prevalence of IDDM ranges from 4.6 (northern Greece) to 42.9 (two regions in Finland) cases per 100 000 per year. I3 In many European populations the strongest HLA-DR association exists with the combination of HLA-DR3 and -DR4.IO This has led to speculation that IDDM susceptibility molecules may be formed in trans (on the same haplotype) as well as cis (between haplo types) configurations, a notion supported by experiments by Nepom who found DQ molecules formed from OR4 DQI3 chains and DR3 DQa chains in DR3/DR4 subjects. 14 However in Finland, which has the highest incidence of IDDM in the world, DR3/DR4 is found in only 21.5% of diabetics compared with 4% of controls. IS This is probably explained by the lower frequency of HLA-OR3 in the background popUlation, and the fact that heterozygote combinations are not so important in this ethnic group in which susceptibility to IDDM is encoded for by genes on a single MHC haplotype.
Although the study of single-locus HLA markers has provided valuable information at the population level and led to the speculation that the DQ region may encode mol ecules directly involved in IDDM, for some years it has been apparent that more information is to be derived from the study of whole MHC haplotypes (i.e. combining mark ers from the class I, II and III regions ).16 A recent example comes from the Finnish DiMe study. Tuomilehto-Wolf and colleagues identified all newly diagnosed cases of IDDM in Finland over a 3-year period; 75S families were recruited into a genetic study.17 It rapidly emerged that an individual's risk of IDOM was predicted better by single MHC haplotypes than by single markers, including those in the DQ region. These haplotypes have widely varying absolute risks for IDDM, with many possessing the high risk OQ combinations (Table 11) . 18 The highest absolute risk of 21S/ 1 00 000 per year is in individuals carrying the haplotype A2-Cwl-Bw56-0R4, whereas another OR4 OQBI *0302 haplotype, A2-Cw4-B35-0R4, which is identical at OQ, has an absolute risk of only 35/ 100 000 -similar to the background population. In an individual, therefore, the risk of 100M is determined by the combination of HLA-A, -B, and -C alleles together with the high-risk OR and OQ alleles.
What are the possible genes on the MHC haplotype which are directly involved in the pathogenesis of 100M? A central role for HLA-OQ molecules in the pathogenesis of 100M has been hypothesised and backed up by some experimental data. The three-dimensional structure of the HLA class II molecule has been deduced from studies of HLA class I molecules, 19 The floor of the antigen-pres enting groove is made of � pleated sheet and the walls of two a helices. In OQ molecules, whilst the i3 pleated sheet is encoded by both OQAl and OQBI genes, the two a helices are encoded separately by OQAI and OQBl. Amino acid substitutions in the groove due to nucleotide substitutions in the OQAI and OQB I genes probably lead to a change in conformation in the antigen-binding groove, thereby affecting antigen recognition and hence the susceptibility to 100M. Tumour necrosis factor (TNF) has an important role in defence against viruses and is also known to regulate expression of HLA molecules. Subjects with certain MHC alleles are known to secrete different levels of TN Fa and TNF� (unpublished observations).2o. 21 Class I molecules could also have a central role in 100M pathogenesis through their interaction with C08 cytotoxic T cells. Foulis and colleagues, by studying autopsy pan creases, have noted that in 100M there is marked hyper expression of HLA class I molecules which precedes the HLA class II expression.22 Additional evidence comes from the pancreatic transplantation studies of Sutherland and colleagues in identical twins discordant for IOOM. 23 The twins were selected if the non-diabetic twin had remained so for at least 30 years after the co-twin had developed 100M, and therefore was most unlikely ever to develop the disease. They transplanted pancreatic tissue from the healthy twin to the diabetic co-twin; however, the previously healthy islet tissue was immediately rejected. Pancreatic histology revealed a heavy lymphocytic infil tration of C08 (cytotoxic) rather than C04 (helper) posi-211 tive cells in the transplanted islets. These transplantation experiments would, therefore, favour a HLA class I restricted process.
Are the HLA associations in diabetes seen only in 100M? HLA associations have been found in a number of different types of diabetes, including gestational diabetes, fibrocalculous pancreatic diabetes and even in some cases of NIOOM.24 As these types of diabetes are not charac terised by insulin dependence and ketoacidosis, beta cell destruction must have been halted and the diabetes devel oped after a secondary insult. Thus in the case of fibrocal culous pancreatic diabetes, the HLA predisposition by itself may have led to limited beta cell destruction but not sufficient to cause diabetes.25 However, with additional pancreatic damage due to chronic pancreatitis, diabetes results.
NON-MHC GENES
The evidence for the involvement of non-MHC genes in 100M has been discussed previously. In total, the non MHC genes probably account for approximately 40% of the genetic contribution to IOOM. 26 Of the many can didates tested, the only consistent association is between 100M and polymorphism in and around the insulin gene on the short arm of chromosome 11. Between 1984 and 1985 several studies demonstrated an association between 100M and the short class I allele in the 5' flanking region of the insulin gene.27. 28 This association has recently been re-studied and confirmed using intragenic insulin gene polymorphisms. 29 In the United Kingdom, the strength of the association is similar to that of HLA-OR4, with a rela tive risk of 4.9 (95% confidence limits 2.7_8.9).28.30 The literature is less clear as to whether the 100M-associated insulin gene alleles are also associated with HLA-OR4. Formal linkage of insulin alleles and 100M is hard to prove because of the major association between HLA and 100M. Nevertheless, several studies by Owerbach, Julier and Raffell and their respective colleagues have shown an increased frequency of insulin gene alleles in the families of 100M probands?9. 31.32 The functional link between insulin gene polymorphism and 100M is harder to under stand. The possibilities include that of the primary associ ation being with a locus in linkage disequilibrium with the insulin gene markers and the product of this locus playing a role in 100M pathogenesis. 30 The alternative hypothesis would be a direct effect related to the insulin gene itself.
Associations of 100M have also been noted with T cell receptor � chain and immunoglobulin heavy chain poly morphisms, although the results of studies have not been consistent.33-37 More recent studies might indicate that these represent a priori associations with microangio pathic complications. A problem of study design in many of these experiments is that they do not have sufficient power to discriminate an association with 100M per se from an independent association with the complication being studied. We have adopted an alternative approach by studying a NIOOM population in which the genes being studied seem highly unlikely to be involved in NIOOM pathogenesis per se. Associations in South Indian NIDDM subjects were found between proliferative ret inopathy and IgA heavy chain gene polymorphism.38 Similar associations have previously been reported in IDDM subjects, thus confirming that for this locus the primary association is probably with retinopathy. With regard to the T cell receptor, Patel and colleagues suggest that the primary association may be between retinopathy and the aldose reductase gene found on the same chro mosome as the gene for the /3 chain of the T cell receptor. 39
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